Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/09/06

Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. announced the submission of a Marketing Authorisation Application (MAA) for ATRIPLA(TM) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) in the European Union to the European Medicines Agency (EMEA)

Today in Marketing/Media/ROI...keeping you current

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

 See all of Marketing/Media/ROI

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address